Predicting clinical outcome of therapy-resistant prostate cancer.
Publication
, Journal Article
Ma, X; Huang, J
Published in: Proc Natl Acad Sci U S A
June 4, 2019
Duke Scholars
Published In
Proc Natl Acad Sci U S A
DOI
EISSN
1091-6490
Publication Date
June 4, 2019
Volume
116
Issue
23
Start / End Page
11090 / 11092
Location
United States
Related Subject Headings
- Prostatic Neoplasms
- Male
- Humans
- Genomics
Citation
APA
Chicago
ICMJE
MLA
NLM
Ma, X., & Huang, J. (2019). Predicting clinical outcome of therapy-resistant prostate cancer. Proc Natl Acad Sci U S A, 116(23), 11090–11092. https://doi.org/10.1073/pnas.1906812116
Ma, Xin, and Jiaoti Huang. “Predicting clinical outcome of therapy-resistant prostate cancer.” Proc Natl Acad Sci U S A 116, no. 23 (June 4, 2019): 11090–92. https://doi.org/10.1073/pnas.1906812116.
Ma X, Huang J. Predicting clinical outcome of therapy-resistant prostate cancer. Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11090–2.
Ma, Xin, and Jiaoti Huang. “Predicting clinical outcome of therapy-resistant prostate cancer.” Proc Natl Acad Sci U S A, vol. 116, no. 23, June 2019, pp. 11090–92. Pubmed, doi:10.1073/pnas.1906812116.
Ma X, Huang J. Predicting clinical outcome of therapy-resistant prostate cancer. Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11090–11092.
Published In
Proc Natl Acad Sci U S A
DOI
EISSN
1091-6490
Publication Date
June 4, 2019
Volume
116
Issue
23
Start / End Page
11090 / 11092
Location
United States
Related Subject Headings
- Prostatic Neoplasms
- Male
- Humans
- Genomics